Managing stress response to control hypertension in type 2 diabetes.
Scollan-Koliopoulos
Melissa
M
Teachers College, Columbia University, New York, NY, USA.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control*; D010353:Patient Education as Topic / Q000379:methods; D012648:Self Care / Q000379:methods; D013312:Stress, Physiological / Q000150:complications* / Q000503:physiopathology / Q000517:prevention & control*; D013315:Stress, Psychological / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors